Semaglutide has a cumulative exposure of over 22 million patient-years." "We will continue to invest in a variety of disease states including diabetes, chronic kidney disease, obesity, CV disease, liver disease, and Alzheimers disease, as seen in our robust clinical development programs and outcome studies," the statement continued
Among adults aged 60 years who were taking a stable dose of levothyroxine, a single-group prospective study demonstrated that 25.7% successfully discontinued therapy while maintaining adequate thyroid function for 1 year
Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits
Kidney Int (2003) 64(3):93949
For weight loss specifically, Phase 2 trial data suggests retatrutide produces greater average weight loss (22-24%) compared to tirzepatide (18-22%) at maximum doses
Tirzepatide is a medication that can reduce your appetite and slow the movement of food as it travels from the stomach to the small intestine